Please Wait
Applying Filters...
menu
    • menu
    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-01-20

    Virtual Booth

    Contact Supplier

    Menu

    Safinamide

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 3,170Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Pharmanovia Acquires Rights To Treatment For Parkinson’s Disease
    Pharmanovia Acquires Rights To Treatment For Parkinson’s Disease

    07 Oct 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241007135751/en

    BUSINESSWIRE
    07 Oct 2024
    Share Share
    Amneal Enters into European Licensing Agreement with Zambon Biotech for IPX203
    Amneal Enters into European Licensing Agreement with Zambon Biotech for IPX203

    27 Feb 2024

    // PRESS RELEASE

    https://www.zambon.com/en/media/press/2024-02-27-amneal-enters-exclusive-european-licensing-agreement-zambon-biotech-ipx203

    PRESS RELEASE
    27 Feb 2024
    Share Share
    Safinamide mesylate by Zambon Co for Multiple System Atrophy Likelihood Approval
    Safinamide mesylate by Zambon Co for Multiple System Atrophy Likelihood Approval

    28 Aug 2023

    // PHARMACEUTICAL TECHNOLOGY

    https://www.pharmaceutical-technology.com/data-insights/safinamide-mesylate-zambon-co-multiple-system-atrophy-msa-or-shy-drager-syndrome-or-multi-system-degeneration-likelihood-of-approval/

    PHARMACEUTICAL TECHNOLOGY
    28 Aug 2023
    Share Share
    Aurobindo's Generic Safinamide Mesylate Receives Approval in the U.S.
    Aurobindo's Generic Safinamide Mesylate Receives Approval in the U.S.

    14 Jun 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215902

    FDA
    14 Jun 2023
    Share Share
    RK Pharma Receives Generic Safinamide Mesylate Approval in the U.S
    RK Pharma Receives Generic Safinamide Mesylate Approval in the U.S

    03 May 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215945

    FDA
    03 May 2023
    Share Share
    Optimus' Generic Safinamide Receives Approval in the U.S.
    Optimus' Generic Safinamide Receives Approval in the U.S.

    12 Jan 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216020

    FDA
    12 Jan 2023
    Share Share